Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial (vol 392, pg 31, 2018)

Jaber S.; Paugam C.; Futier E.

首页> 外文期刊>The Lancet >Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial (vol 392, pg 31, 2018)

【24h】

Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial (vol 392, pg 31, 2018)

机译：重症监护病房（Bicar-ICU）中严重代谢嗜血症患者的碳酸氢钠治疗（BICAR-ICU）：多期，开放标签，随机控制，第3阶段试验（Vol 392，PG 31,2018）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Lancet》 |2018年第10163期|共1页
作者
Jaber S.; Paugam C.; Futier E.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献

1. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial (vol 392, pg 31, 2018) [J] . Jaber S., Paugam C., Futier E. The Lancet . 2018,第10163期

机译：重症监护病房（Bicar-ICU）中严重代谢嗜血症患者的碳酸氢钠治疗（BICAR-ICU）：多期，开放标签，随机控制，第3阶段试验（Vol 392，PG 31,2018）
2. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial [J] . Jaber Samir, Paugam Catherine, Futier Emmanuel, The Lancet . 2018,第10141期

机译：重症监护病房（Bicar-ICU）中严重代谢症症患者的碳酸氢钠治疗（BICAR-ICU）：多期，开放标签，随机控制，第3期试验
3. Sodium Bicarbonate Therapy for Patients with Severe Metabolic Acidaemia in the Intensive Care Unit?(BICAR-ICU): a Multicentre, Open-Label, Randomised Controlled, Phase 3 Trial [J] . Nicholas Kelly The Journal of Emergency Medicine . 2018,第5期

机译：碳酸氢钠治疗重症监护单位严重代谢症症患者？（Bicar-ICU）：多期，开放标签，随机控制，第3阶段试验
4. Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients ImmunoSABR: a multicentre randomised controlled open-label phase II trial [O] . Relinde I. Y. Lieverse, Evert J. Van Limbergen, Cary J. G. Oberije, 2020

机译：立体定向烧蚀身体放射疗法（SABR）联合免疫疗法（L19-IL2）与IV阶段NSCLC患者的护理标准免疫疗法：多期随机控制的开放标签期II试验
5. Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting:A randomised, open-label, blinded-endpoint, controlled trial in a health-care setting [O] . Caterina, Breitenstein, Grewe, Tanja, Flöel, Agnes, 2017

机译：中风后慢性失语症患者的强化言语和语言治疗：在卫生保健环境中进行的一项随机，开放标签，盲法终点对照试验：一项健康的随机，开放标签，盲法终点对照试验护理设置

Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial (vol 392, pg 31, 2018)

著录项

相似文献

相关主题

期刊订阅